Lv5
1164 积分 2023-06-02 加入
New payloads drive next-gen antibody–drug conjugates
19天前
已完结
Chemical Evolution of Antibody–Drug Conjugates Focused on Linker Design and Conjugation Strategies in Hematology
2个月前
已完结
Recent Advances in Peptide Linkers for Antibody-Drug Conjugates
2个月前
已完结
Recent Advances in Peptide Linkers of Antibody–Drug Conjugates
2个月前
已完结
Precision chemical synthesis of PEGylated IGF2 for potent and selective lysosomal degradation of transmembrane proteins
2个月前
已完结
Modular Assembly of Bioconjugates Enabled by a Pyridine‐Based Chemoselective Sequential Conjugation Platform
2个月前
已完结
Two decades of PARP inhibitor synthetic lethality in cancer
2个月前
已完结
Design, development, and therapeutic applications of PARP-1 selective inhibitors
2个月前
已完结
Research progress and development strategies of antibody-oligonucleotide conjugates
2个月前
已完结
Design and synthesis of novel 4-aryl-2-benzoyl-imidazoles as colchicine binding site inhibitors
2个月前
已完结
皖公网安备34019202002308
